Answer
Cinryze is indicated from 2 years of age for treating hereditary angioedema attacks and preventing attacks before procedures, including in adolescents and adults.
Sources for this answer
- Cinryze 500 IU powder and solvent for solution for injectionTakeda UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 19Document updated
Sources checked